Brasterapica Indústria Farmacêutica

What Brasterapica Indústria Farmacêutica does

Brasterápica Indústria Farmacêutica is a privately held Brazilian manufacturer of pharmaceutical and nutraceutical products, headquartered in Atibaia (São Paulo state), Brazil. The company was founded in 2014 and operates with a headcount in the 51-100 range, placing it in the small-to-mid Brazilian CDMO/own-brand manufacturer segment. Its functional scope, as described in available firmographic data, is the development and manufacture of a range of pharmaceutical and nutraceutical products, serving downstream customers in the Brazilian health-products market.

No additional operational detail was recoverable from the source material. The company website (brasterapica.com.br) returned only a bot-verification interstitial ("One moment, please... Please wait while your request is being verified") rather than substantive product, customer, regulatory, or pricing content. As a result, the company's specific product portfolio, therapeutic areas, dosage forms, manufacturing certifications (e.g., ANVISA GMP status), customer segments (OTC pharmacy chains, distributors, hospitals, B2B contract manufacturing), revenue model, and go-to-market motion are not documented in the available data. No funding rounds, M&A activity, partnerships, leadership roster, awards, or patents were captured either.

The analytical baseline is therefore limited to the static firmographic record: a decade-old, privately held, small-scale Brazilian pharmaceutical and nutraceutical manufacturer with a single known location in Atibaia. The company has not raised external capital according to available data, suggesting organic growth or founder-funded operations. The lack of observable product, customer, and revenue detail constitutes a material information gap for any investment, partnership, or M&A assessment.

Name

Brasterapica Indústria Farmacêutica

Website

https://brasterapica.com.br

Company type

Private

Founded year

2014

Headcount range

51–100 employees

Short description

Brasterápica Indústria Farmacêutica is a privately held Brazilian manufacturer founded in 2014, based in Atibaia, that develops and produces pharmaceutical and nutraceutical products for the Brazilian health-products market. It operates with a small-to-mid headcount of 51-100 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYAFAJAFAF

Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts)

Agriculture & Food Production/Food Ingredients & Additives/Preservatives & Antimicrobials (Organic Acids, Nitrates, Cultured Dextrose)

Keywords

• Pharmaceutical manufacturing
• Nutraceutical products
• Drug formulation
• Pharmaceutical industry
• Nutritional supplements

Headquarters

HQ city

Atibaia

HQ country

Brazil

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D

Core offering

Brasterápica Indústria Farmacêutica develops and manufactures a range of pharmaceutical and nutraceutical products. The company operates as a private Brazilian pharmaceutical manufacturer headquartered in Atibaia, Brazil, founded in 2014.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• EMS Pharma: EMS is Brazil's largest domestic pharmaceutical manufacturer with broad generics, branded generics, OTC, and prescription portfolios. As a Brazilian pharma manufacturer serving similar institutional, retail, and government channels via CMED-regulated products, EMS is the most direct comparable for Brasterápica, though at vastly greater scale.
• Hypera (Hyper Pharma / Hypera S.A.): Hypera is Brazil's largest pharma company by revenue, with strong OTC, generics, and personal care brands plus a history of acquiring smaller domestic manufacturers. As the most active strategic acquirer of small Brazilian pharma/nutraceutical assets, it is a direct peer and a likely buyer or partner for a company at Brasterápica's scale.
• Medley (Sanofi Brasil): Medley is a Brazilian generics manufacturer acquired by Sanofi that operates domestically within the same CMED-regulated framework for prescription and OTC products. Comparable to Brasterápica as a Brazilian pharma manufacturer selling into the same institutional and retail channels.
• Eurofarma Laboratórios: Eurofarma is a privately-held Brazilian pharmaceutical company developing and manufacturing branded generics, prescription, and hospital products. Its vertically integrated develop-and-manufacture model in Brazil mirrors Brasterápica's described structure, making it a direct peer despite Eurofarma's much larger footprint and Latin-American exports.
• Herbarium Laboratório Botânico: Herbarium is a Brazilian manufacturer of plant-derived medicines, phytotherapeutics, and nutraceuticals. It is one of the closest direct peers to Brasterápica given the overlap between botanical pharmaceutical products and nutraceutical categories — the same space Brasterápica's name ("Bras-terápica" = Brazil + therap-etics) implies.
• Laboratório Cristália: Cristália is a privately-held Brazilian pharmaceutical manufacturer focused on hospital, anesthetics, and specialty generics, with its own API and formulation capabilities. It is a direct peer because of the domestic develop-and-manufacture model serving Brazilian institutional and SUS channels under CMED regulation.
• Biolab Farmacêutica: Biolab is a Brazilian pharma company with branded generics, prescription, and supplement/nutraceutical lines. Comparable to Brasterápica because both target the same Brazilian retail and prescription channels with a mix of pharma and nutraceutical products developed and manufactured domestically.
• Aché Laboratórios Farmacêuticos: Aché is a major Brazilian pharmaceutical manufacturer with a mix of prescription, OTC, and dermocosmetic lines. It is a direct peer because it operates the same domestic develop-and-manufacture business model for similar CMED-regulated product categories, including nutraceutical-adjacent supplements, and serves the same Brazilian retail and institutional buyers.
• Natulab Laboratório de Alimentos e Produtos Nutricionais: Natulab is a Brazilian manufacturer of nutraceuticals, supplements, and natural products sold through retail pharmacies. Comparable to Brasterápica because both serve Brazilian nutraceutical/pharmaceutical buyers via similar channel structures and fall under the same ANVISA regulatory categories for supplements.

Broad incumbents

• Sanofi Brasil: Sanofi is a global pharmaceutical company with established operations across prescription, vaccines, consumer health, and generics in Brazil. It is a broad incumbent comparable to Brasterápica in the sense that both develop and manufacture pharmaceutical products for Brazilian patients, though Sanofi operates a vastly broader international portfolio.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/brasterapica

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brasterapica Indústria Farmacêutica